Market Overview:
The global formalin vial market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for formalin vials in hospitals, clinics, and diagnostic laboratories across the globe. In addition, rising awareness about the benefits of using formalin vials is also contributing to the growth of this market. Based on type, below 10 ml segment accounted for a major share of the global formalin vial market in 2017 and is projected to maintain its dominance during the forecast period. This can be attributed to their low cost as compared with other types of formalin vials. Based on application, hospital segment held a dominant share of the global market in 2017 and is projected to maintain its lead duringthe forecast period owingto increase in numberof surgeries performed worldwide coupled with rising demand for pathology services.
Product Definition:
A Formalin Vial is a container that holds formaldehyde, which is a chemical used to preserve tissue specimens.
Below10 ml:
Below10 ml is a new concept in the market of medical storage vials. It’s an airtight container with a small hole at the bottom for releasing pressure and filling liquid medicines. The size of below10 ml vial is ideal to store drugs or chemicals that have low volume but high concentration such as insulin, blood thinner, local anesthetics and many more.
10 - 20 ml:
10 - 20 ml is a size of medical injectable that contains sterile solution of formaldehyde. It's most commonly used in histology and cytology samples for fixation, staining & processing before microscopic observation. 10 - 20 ml can be colorless or contain the addition of coloring agents to make it blue or green depending on the application requirement.
Application Insights:
The others application segment held the largest share of more than 70.0% in 2017. Formalin is used for various applications including hospital, clinics, diagnostic laboratories and other places where formalin-based disinfectants are required. The others application segment includes government centers, healthcare facilities and private offices/hospitals etc., Formalin is used as a sterilization agent in these places due to its ability to eliminate most bacteria including salmonella, staphylococcus Aureus (golden staph), Escherichia coli O157:H7 (eaten by C57BL/6 mice) and Candida albicans (yeast).
Formalin solution has been found useful against Methicillin-resistant Staphylococcus aureus or MRSA which includes methicillin-resistant S. aureus strains such as golden stafs that are resistant to multiple antibiotics such as penicillin G potassium salt & amoxicillin among others.
Regional Analysis:
North America was the largest regional formaldehyde vial market in 2017. The region is anticipated to maintain its dominance over the forecast period owing to increasing incidence of cancer and other chronic diseases. In addition, rising adoption of nuclear medicine procedures is also expected to drive demand for formaldehyde in this region.
Asia Pacific is projected to be the fastest-growing regional market from 2018 to 2030 due high prevalence of chronic diseases such as cancer and diabetes that require frequent blood transfusion & plasma therapy procedures, thereby driving demand for vials containing formaldehyde. Moreover, growing medical tourism industry will also contribute towards growth in this region. For instance, as per a white paper on Export Health Services by Directorate-General of Commercial Intelligence and Statistics (DGCI&S) India; from 2014 till date; India has been attracting more than 100 thousand medical tourists annually who are spending around USD X million on hospital services during their visits which include consultation fees as well as hotel expenses etc.
Growth Factors:
- Increasing demand for formalin in the medical and pharmaceutical industries as a preservative and disinfectant.
- Rising demand from developing countries due to increasing awareness about the benefits of using formalin for preservation and disinfection purposes.
- Growing use of formalin in food processing industry as a preservative to increase shelf life of food products.
- Increasing research on new applications of formalin such as its use in water treatment plants to reduce water pollution levels 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Formalin Vial Market Research Report
By Type
Below10 ml, 10 - 20 ml, 20 - 40 ml, 40 - 60 ml, 60 - 90 ml, 90 - 500 ml, 500 ml - 1 litre
By Application
Hospital, Clinic, Diagnostic Laboratories, Others
By Companies
Kadmon Holdings, Diapath, Leica Biosystems Nussloch, Genta Environmental, Carl Roth, Magnacol, Serosep, Thermo Fisher Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Formalin Vial Market Report Segments:
The global Formalin Vial market is segmented on the basis of:
Types
Below10 ml, 10 - 20 ml, 20 - 40 ml, 40 - 60 ml, 60 - 90 ml, 90 - 500 ml, 500 ml - 1 litre
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Diagnostic Laboratories, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Kadmon Holdings
- Diapath
- Leica Biosystems Nussloch
- Genta Environmental
- Carl Roth
- Magnacol
- Serosep
- Thermo Fisher Scientific
Highlights of The Formalin Vial Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Below10 ml
- 10 - 20 ml
- 20 - 40 ml
- 40 - 60 ml
- 60 - 90 ml
- 90 - 500 ml
- 500 ml - 1 litre
- By Application:
- Hospital
- Clinic
- Diagnostic Laboratories
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Formalin Vial Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Formalin is a preservative that is used to preserve specimens. It is also used in some medical procedures, such as autopsies.
Some of the major companies in the formalin vial market are Kadmon Holdings, Diapath, Leica Biosystems Nussloch, Genta Environmental, Carl Roth, Magnacol, Serosep, Thermo Fisher Scientific.
The formalin vial market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Formalin Vial Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Formalin Vial Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Formalin Vial Market - Supply Chain
4.5. Global Formalin Vial Market Forecast
4.5.1. Formalin Vial Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Formalin Vial Market Size (000 Units) and Y-o-Y Growth
4.5.3. Formalin Vial Market Absolute $ Opportunity
5. Global Formalin Vial Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Formalin Vial Market Size and Volume Forecast by Type
5.3.1. Below10 ml
5.3.2. 10 - 20 ml
5.3.3. 20 - 40 ml
5.3.4. 40 - 60 ml
5.3.5. 60 - 90 ml
5.3.6. 90 - 500 ml
5.3.7. 500 ml - 1 litre
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Formalin Vial Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Formalin Vial Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.3.3. Diagnostic Laboratories
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Formalin Vial Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Formalin Vial Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Formalin Vial Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Formalin Vial Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Formalin Vial Demand Share Forecast, 2019-2026
9. North America Formalin Vial Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Formalin Vial Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Formalin Vial Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.4.3. Diagnostic Laboratories
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Formalin Vial Market Size and Volume Forecast by Type
9.7.1. Below10 ml
9.7.2. 10 - 20 ml
9.7.3. 20 - 40 ml
9.7.4. 40 - 60 ml
9.7.5. 60 - 90 ml
9.7.6. 90 - 500 ml
9.7.7. 500 ml - 1 litre
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Formalin Vial Demand Share Forecast, 2019-2026
10. Latin America Formalin Vial Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Formalin Vial Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Formalin Vial Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.4.3. Diagnostic Laboratories
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Formalin Vial Market Size and Volume Forecast by Type
10.7.1. Below10 ml
10.7.2. 10 - 20 ml
10.7.3. 20 - 40 ml
10.7.4. 40 - 60 ml
10.7.5. 60 - 90 ml
10.7.6. 90 - 500 ml
10.7.7. 500 ml - 1 litre
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Formalin Vial Demand Share Forecast, 2019-2026
11. Europe Formalin Vial Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Formalin Vial Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Formalin Vial Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.4.3. Diagnostic Laboratories
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Formalin Vial Market Size and Volume Forecast by Type
11.7.1. Below10 ml
11.7.2. 10 - 20 ml
11.7.3. 20 - 40 ml
11.7.4. 40 - 60 ml
11.7.5. 60 - 90 ml
11.7.6. 90 - 500 ml
11.7.7. 500 ml - 1 litre
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Formalin Vial Demand Share, 2019-2026
12. Asia Pacific Formalin Vial Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Formalin Vial Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Formalin Vial Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.4.3. Diagnostic Laboratories
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Formalin Vial Market Size and Volume Forecast by Type
12.7.1. Below10 ml
12.7.2. 10 - 20 ml
12.7.3. 20 - 40 ml
12.7.4. 40 - 60 ml
12.7.5. 60 - 90 ml
12.7.6. 90 - 500 ml
12.7.7. 500 ml - 1 litre
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Formalin Vial Demand Share, 2019-2026
13. Middle East & Africa Formalin Vial Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Formalin Vial Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Formalin Vial Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.4.3. Diagnostic Laboratories
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Formalin Vial Market Size and Volume Forecast by Type
13.7.1. Below10 ml
13.7.2. 10 - 20 ml
13.7.3. 20 - 40 ml
13.7.4. 40 - 60 ml
13.7.5. 60 - 90 ml
13.7.6. 90 - 500 ml
13.7.7. 500 ml - 1 litre
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Formalin Vial Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Formalin Vial Market: Market Share Analysis
14.2. Formalin Vial Distributors and Customers
14.3. Formalin Vial Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Kadmon Holdings
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Diapath
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Leica Biosystems Nussloch
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Genta Environmental
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Carl Roth
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Magnacol
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Serosep
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Thermo Fisher Scientific
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
